Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
UCB [BE0003739530/UCB]   
[19/09/2018]

UCB : UCB Media Room: Transparency Notification

Transparency notifications BlackRock, Inc.3 notifications referring to situation on 12, 14 and 17 September 2018Threshold crossed: 5%Latest holding: 4.96%Brussels Belgium, 19 September 2018 – 20:00 CEST – regulated information1. Summary of the notificationsPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 3... See more
 
UCB [BE0003739530/UCB]   
[14/09/2018]

UCB : UCB Media Room: Transparency Notification

Transparency notification BlackRock, Inc.Brussels Belgium, 14 September 2018 – 20:00 CEST – regulated information1. Summary of the notificationPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification from BlackRock, Inc. having its registered office at 55 East 52nd Street, New York, NY,... See more
 
UCB [BE0003739530/UCB]   
[13/09/2018]

UCB : UCB Media Room: EADV Data Highlights Release

Data Presented at EADV 2018 Further Demonstrate the Value of CIMZIA® certolizumab pegol and Bimekizumab, as UCB Commitment to Psoriasis and ImmunoDermatology GrowsPooled data from three Phase 3 psoriasis studies focus on CIMZIA® certolizumab pegol dose durability of treatment response through 48 weeksTwo subanalyses from the Phase 3 CIMPACT study show the potential value of CIMZIA for psoriasis... See more
 
UCB [BE0003739530/UCB]   
[05/09/2018]

UCB : UCB Media Room: Transparency Notification

Transparency notification BlackRock, Inc.Brussels Belgium, 5 September 2018 – 20:00 CEST – regulated information1. Summary of the notificationPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification from BlackRock, Inc. having its registered office at 55 East 52nd Street, New York, NY, 10055,... See more
 
UCB [BE0003739530/UCB]   
[31/08/2018]

UCB : UCB Media Room: Transparency Notification

Transparency notification BlackRock, Inc.Brussels Belgium, 31 August 2018 – 20:00 CEST – regulated information1. Summary of the notificationPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification from BlackRock, Inc. having its registered office at 55 East 52nd Street, New York, NY, 10055,... See more
 
UCB [BE0003739530/UCB]   
[29/08/2018]

UCB : UCB Media Room: Transparency Notification

Transparency notifications BlackRock, Inc.2 notifications referring to situation on 23 August and 24 August 2018Threshold crossed: 5%Latest holding: 4.95%Brussels Belgium, 29 August 2018 – 20:00 CEST – regulated information1. Summary of the notificationsPursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 2... See more
 
UCB [BE0003739530/UCB]   
[13/08/2018]

UCB : UCB Media Room: FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray

FDA Accepts New Drug Application NDA to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clustersMidazolam Nasal Spray has been granted orphan drug designation by the United States Food and Drug Administration US FDA for the rescue treatment of seizures in patients who require control of intermittent bouts of increased seizure activity e.g. seizure... See more
 
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...